PP37 IS RIFAXIMIN ENOUGH SAFE AND EFFECTIVE IN PEDIATRIC IBS?

Autor:	F. Fiore, S. Filoni, C. Fantacci, V. Giorgio, Carlo Fundarò, V. Ansuini
Rok vydání:	2009
Předmět:	medicine.medical_specialty chemistry.chemical_compound Hepatology chemistry business.industry Gastroenterology medicine Intensive care medicine business Rifaximin
Zdroj:	Digestive and Liver Disease. 41:S217
ISSN:	1590-8658
DOI:	10.1016/s1590-8658(09)60494-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8011f11b101b6ecf39a55d094ff39b85 https://doi.org/10.1016/s1590-8658(09)60494-1 Zobrazit plný text záznamu Full Text from ScienceDirect